HK1017359A1 - Tetrahydropyrrolofuropyridin e-dione derivatives for use in controlling endoparasites, a method for producing the same and use thereof - Google Patents

Tetrahydropyrrolofuropyridin e-dione derivatives for use in controlling endoparasites, a method for producing the same and use thereof

Info

Publication number
HK1017359A1
HK1017359A1 HK99102642A HK99102642A HK1017359A1 HK 1017359 A1 HK1017359 A1 HK 1017359A1 HK 99102642 A HK99102642 A HK 99102642A HK 99102642 A HK99102642 A HK 99102642A HK 1017359 A1 HK1017359 A1 HK 1017359A1
Authority
HK
Hong Kong
Prior art keywords
tetrahydropyrrolofuropyridin
producing
same
dione derivatives
controlling endoparasites
Prior art date
Application number
HK99102642A
Other languages
English (en)
Inventor
Peter Jeschke
Achim Harder
Norbert Mencke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HK1017359A1 publication Critical patent/HK1017359A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541Non-condensed thiazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK99102642A 1995-10-19 1999-06-21 Tetrahydropyrrolofuropyridin e-dione derivatives for use in controlling endoparasites, a method for producing the same and use thereof HK1017359A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19538960A DE19538960A1 (de) 1995-10-19 1995-10-19 4a,5a,8a,8b-Tetrahydro-6H-pyrrolo [3',4':4,5] furo [3,2-b] pyridin-6,8(7H)-dion Derivate zur Bekämpfung von Endoparasiten, Verfahren zu ihrer Herstellung
PCT/EP1996/004346 WO1997014695A1 (de) 1995-10-19 1996-10-07 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO[3',4':4,5]FURO [3,2-b]PYRIDIN-6,8(7H)-DION DERIVATE ZUR BEKÄMPFUNG VON ENDOPARASITEN UND VERFAHREN ZU IHRER HERSTELLUNG

Publications (1)

Publication Number Publication Date
HK1017359A1 true HK1017359A1 (en) 1999-11-19

Family

ID=7775277

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102642A HK1017359A1 (en) 1995-10-19 1999-06-21 Tetrahydropyrrolofuropyridin e-dione derivatives for use in controlling endoparasites, a method for producing the same and use thereof

Country Status (24)

Country Link
US (2) US6110928A (no)
EP (1) EP0871630B1 (no)
JP (1) JP4157163B2 (no)
KR (1) KR100444144B1 (no)
CN (1) CN1111535C (no)
AR (1) AR004023A1 (no)
AT (1) ATE211475T1 (no)
AU (1) AU706836B2 (no)
BR (1) BR9611002B1 (no)
CZ (1) CZ295075B6 (no)
DE (2) DE19538960A1 (no)
DK (1) DK0871630T3 (no)
ES (1) ES2170271T3 (no)
HK (1) HK1017359A1 (no)
HU (1) HUP9802854A3 (no)
NO (1) NO323609B1 (no)
NZ (1) NZ320174A (no)
PL (1) PL185960B1 (no)
PT (1) PT871630E (no)
SK (1) SK284914B6 (no)
TR (1) TR199800686T2 (no)
TW (1) TW466241B (no)
WO (1) WO1997014695A1 (no)
ZA (1) ZA968788B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19719839A1 (de) * 1997-05-12 1998-11-19 Bayer Ag 6-Substituierte 1,2,4a,5a,8a,8b-Hexahydro- und 1,2,3,4,4a,5a,8a,8b-Oktahydro-6H-pyrrolo/3',4':4,5/furo/3,2-b/pyrid-8(7H)-on Derivate und ihre Verwendung zur Bekämpfung von Endoparasiten
DE10201544A1 (de) * 2002-01-17 2003-07-31 Bayer Cropscience Ag Substituierte Pyrazoline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4032090A1 (de) * 1990-02-13 1991-08-14 Bayer Ag Polycyclische 3-aryl-pyrrolidin-2,4-dion-derivate
DE4121365A1 (de) * 1991-06-28 1993-01-14 Bayer Ag Substituierte 1-h-3-aryl-pyrrolidin-2,4-dion-derivate

Also Published As

Publication number Publication date
AU7286596A (en) 1997-05-07
PT871630E (pt) 2002-06-28
CN1204335A (zh) 1999-01-06
PL326323A1 (en) 1998-09-14
SK284914B6 (sk) 2006-02-02
CZ295075B6 (cs) 2005-05-18
HUP9802854A2 (hu) 1999-05-28
CZ118898A3 (cs) 1998-08-12
DK0871630T3 (da) 2002-04-29
EP0871630A1 (de) 1998-10-21
NO981502L (no) 1998-04-02
DE19538960A1 (de) 1997-04-24
TW466241B (en) 2001-12-01
BR9611002A (pt) 1999-07-13
CN1111535C (zh) 2003-06-18
JP4157163B2 (ja) 2008-09-24
KR19990063812A (ko) 1999-07-26
KR100444144B1 (ko) 2005-01-13
TR199800686T2 (xx) 1998-07-21
DE59608617D1 (de) 2002-02-28
ES2170271T3 (es) 2002-08-01
EP0871630B1 (de) 2002-01-02
ZA968788B (en) 1996-12-03
BR9611002B1 (pt) 2010-11-30
JPH11513675A (ja) 1999-11-24
NZ320174A (en) 2000-12-22
NO323609B1 (no) 2007-06-18
WO1997014695A1 (de) 1997-04-24
AR004023A1 (es) 1998-09-30
US6110928A (en) 2000-08-29
AU706836B2 (en) 1999-06-24
PL185960B1 (pl) 2003-09-30
HUP9802854A3 (en) 2001-12-28
US6291472B1 (en) 2001-09-18
NO981502D0 (no) 1998-04-02
ATE211475T1 (de) 2002-01-15
SK49298A3 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
GB2291007B (en) Decorative sheet and method for producing the same
HK1031382A1 (en) Spiroazabicyclic heterocyclic compounds, a method for producing the same and use thereof
SG77575A1 (en) Workpiece retaining device and method for producing the same
HUP9601465A2 (en) Metallocenes, method for their preparation and use
EP1022284A4 (en) TAXOID DERIVATIVES AND METHOD FOR THEIR PRODUCTION
AU1943699A (en) Patterned coated articles and methods for producing the same
AU2839297A (en) Absorbent article and method for producing the same
HUP9900339A3 (en) Water-soluble copolymers, process for producing the same and their use
HUP0000449A3 (en) N-subsituted dioxothiazolidylbenzamide derivatives and process for producing the same
EP0785205A4 (en) 2-SILYLOXYTETRAHYDROTHIENOPYRIDINE, ITS SALT, AND ITS PRODUCTION METHOD
AU5855498A (en) Monoolefinic c5-mononitriles, method for the production and the use thereof
AU4188196A (en) Organobismuth derivatives and process for producing the same
AU4384097A (en) A nonwoven composite, a method for the production thereof and a use thereof
AU5123996A (en) Bactericidal mat, process for producing the same, and use thereof
SG46741A1 (en) Pyridazinone derivatives and processes for preparing the same
HK1029114A1 (en) Thiodepsipeptides for combating endoparasites and a method for producing the same
AU7809198A (en) Electoluminescent device and method for producing the same
HUP9901982A3 (en) Web-shaped semifinished product, in particular wall covering plaster, and process for producing the same
EP0799842A4 (en) BLOCK COPOLYMERS AND METHOD FOR THE PRODUCTION THEREOF
EP0693474A4 (en) NEW BENZYLAMINOETHOXYBENZENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
ZA973433B (en) A sertindole-containing preparation and a method for producing the same.
HUP9802316A3 (en) Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
SG75834A1 (en) Laminate and process for producing the same
AU5645598A (en) New benzoxazinedione derivatives, a method of producing them and the use thereof
AU6333199A (en) Webbing and method for producing the same

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121007